COMPANY PROFILE // THE 014 REPORT
Imunon, Inc.
IMNN (Nasdaq) · Formerly: CELSION CORP; Celsion CORP; CHEUNG LABORATORIES INC
Assembled from 2 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber6 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-08-11: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-08-28 and 4 more times (last 24 months).
- InfoUSAspending recipient T47TFH41YJF8 (matched to this company by exact name) has no entity registration in the SAM.gov public extract of 2026-11-01.possible match
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Imunon, Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in DE, based in Lawrenceville, NJ; listed as IMNN (Nasdaq).[source] It has filed 101 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are ARMISTICE CAPITAL, LLC, Riverview Capital Advisers, LLC, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; 6 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-08-11.[source]
- red0
- amber2
- info1
- ARMISTICE CAPITAL, LLC$258K
- Riverview Capital Advisers, LLC$248K
- VANGUARD CAPITAL MANAGEMENT LLC$84K
- GEODE CAPITAL MANAGEMENT, LLC$56K
- VANGUARD FIDUCIARY TRUST CO$24K
- NORTHERN TRUST CORP$18K
- UBS Group AG$9K
- BlackRock, Inc.$8K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Anwer Khursheed · Chief Scientific Officer (Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- Bragg Kimberly · CFO (Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- CHURCH JEFFREY WAYNE · CFO (Officer) · latest Form 3 2026-01-20 · filing · LinkedIn search
- Eylward Susan · General Counsel and Corp Sec (Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- Faller Douglas Vincent · Chief Medical Officer (Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- Lindborg Stacy · President and CEO (Director,Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- Tardugno Michael H · Executive Chairman of Board (Director,Officer) · latest Form 4 2026-01-06 · filing · LinkedIn search
- Braun Donald P · Director · latest Form 4 2026-01-06 · filing · LinkedIn search
- Dentzer James E · Director · latest Form 4 2026-01-06 · filing · LinkedIn search
- Fritz Frederick J. · Director · latest Form 4 2026-01-06 · filing · LinkedIn search
- Pellizzari Christine A · Director · latest Form 4 2026-01-06 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Thompson Hine LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-06-17
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000749647 | source |
| UEIpossible match | T47TFH41YJF8 | source |
| EIN | 52-1256615 | source |
| Business address (SEC) | 997 LENOX DRIVE, LAWRENCEVILLE, NJ, 08648 | source |
Does not exist in the records we hold: LEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- CURIS INC · Dentzer James E
- Tempest Therapeutics, Inc. · Pellizzari Christine A
- NeuroSense Therapeutics Ltd. · Pellizzari Christine A
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-28 filing S-1/A · SEC EDGAR
- 2026-10-27 filing Registration (S-1) · SEC EDGAR
- 2026-10-27 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-10-21 filing 8-K items 1.01,7.01,9.01 · SEC EDGAR
- 2026-10-13 filing DRS · SEC EDGAR
- 2026-09-29 filing 8-K items 1.01,3.02,5.03,9.01 · SEC EDGAR
- 2026-08-11 officer change 8-K items 5.02 · SEC EDGAR
- 2026-08-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-06-30 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-06-17 filing S-8 · SEC EDGAR
- 2026-06-16 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
- 2026-06-04 filing 8-K items 1.01,2.03,3.02,5.03,7.01,9.01 · SEC EDGAR
- 2026-05-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-05-04 filing ARS · SEC EDGAR
- 2026-05-04 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-05-04 filing Proxy statement · SEC EDGAR
- 2026-03-31 filing Annual report (10-K) · SEC EDGAR
- 2026-03-31 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-03-23 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-03-23 filing 424B5 · SEC EDGAR
- 2026-02-05 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-01-20 insider First Form 3/4/5 on record for CHURCH JEFFREY WAYNE (CFO) · SEC Forms 3/4/5
- 2026-01-07 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-01-06 insider First Form 3/4/5 on record for Faller Douglas Vincent (Chief Medical Officer) · SEC Forms 3/4/5
- 2025-12-31 filing 424B5 · SEC EDGAR
- 2025-12-31 filing 8-K items 1.01,8.01,9.01 · SEC EDGAR
170 earlier entries
- 2025-11-13 filing S-8
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-11-13 filing 8-K items 2.02,9.01
- 2025-09-10 filing UPLOAD
- 2025-08-28 filing 8-K items 3.01,9.01
- 2025-08-13 filing CORRESP
- 2025-08-06 insider First Form 3/4/5 on record for Anwer Khursheed (Chief Scientific Officer)
- 2025-08-06 insider First Form 3/4/5 on record for Eylward Susan (General Counsel and Corp Sec)
- 2025-08-06 insider First Form 3/4/5 on record for Lindborg Stacy (President and CEO)
- 2025-08-06 insider First Form 3/4/5 on record for Tardugno Michael H (Executive Chairman of Board)
- 2025-08-06 insider First Form 3/4/5 on record for Braun Donald P (Director)
- 2025-08-06 insider First Form 3/4/5 on record for Dentzer James E (Director)
- 2025-08-06 insider First Form 3/4/5 on record for Fritz Frederick J. (Director)
- 2025-08-06 insider First Form 3/4/5 on record for Pellizzari Christine A (Director)
- 2025-08-05 filing Quarterly report (10-Q)
- 2025-08-05 filing 8-K items 2.02,9.01
- 2025-08-04 filing UPLOAD
- 2025-07-28 filing 8-K items 8.01,9.01
- 2025-07-23 filing 8-K items 3.03,5.03,7.01,8.01,9.01
- 2025-07-22 filing 8-K items 8.01,9.01
- 2025-07-22 filing 424B5
- 2025-07-14 officer change 8-K items 3.01,5.02
- 2025-07-11 filing 8-K items 3.03,5.03,5.07,9.01
- 2025-06-17 insider First Form 3/4/5 on record for Bragg Kimberly (CFO)
- 2025-06-13 filing EFFECT
- 2025-06-13 officer change 8-K items 5.02,9.01
- 2025-06-13 filing 424B3
- 2025-06-11 filing ARS
- 2025-06-11 filing CORRESP
- 2025-06-09 filing Proxy statement
- 2025-06-09 filing 8-K items 8.01
- 2025-06-05 filing UPLOAD
- 2025-05-30 filing CORRESP
- 2025-05-30 filing Registration (S-1)
- 2025-05-30 filing PRE 14A
- 2025-05-30 filing 8-K items 3.01
- 2025-05-28 filing D
- 2025-05-27 filing 8-K items 1.01,3.02,8.01,9.01
- 2025-05-22 filing 8-K items 8.01
- 2025-05-22 filing RW
- 2025-05-20 filing 8-K items 3.01
- 2025-05-19 filing S-1/A
- 2025-05-13 filing S-1/A
- 2025-05-13 filing 8-K items 1.01,3.02,9.01
- 2025-05-12 filing Quarterly report (10-Q)
- 2025-05-12 filing 8-K items 2.02,9.01
- 2025-04-04 filing Registration (S-1)
- 2025-03-24 filing 8-K items 8.01,9.01
- 2025-03-19 filing DRS
- 2025-02-27 filing Annual report (10-K)
- 2025-02-27 filing 8-K items 2.02,9.01
- 2025-02-10 officer change 8-K items 5.02,7.01,9.01
- 2024-11-27 filing 8-K items 3.01
- 2024-11-07 filing 8-K items 2.02,9.01
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-10-07 officer change 8-K items 5.02,7.01,9.01
- 2024-09-27 filing 424B3
- 2024-09-26 filing EFFECT
- 2024-09-24 filing CORRESP
- 2024-09-20 filing S-1/A
- 2024-09-05 filing UPLOAD
- 2024-09-03 filing 8-K items 8.01,9.01
- 2024-09-03 filing 424B5
- 2024-08-29 filing Registration (S-1)
- 2024-08-29 filing S-8
- 2024-08-16 filing D
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-08-14 filing 8-K items 2.02,9.01
- 2024-08-01 filing 8-K items 8.01,9.01
- 2024-08-01 filing 424B5
- 2024-07-31 filing 8-K items 1.01,3.02,8.01,9.01
- 2024-07-30 filing 8-K items 7.01,8.01,9.01
- 2024-06-13 filing 8-K items 5.07,9.01
- 2024-05-22 filing EFFECT
- 2024-05-20 filing CORRESP
- 2024-05-20 filing UPLOAD
- 2024-05-20 officer change 8-K items 5.02,9.01
- 2024-05-15 filing S-3
- 2024-05-13 filing Quarterly report (10-Q)
- 2024-05-13 filing 8-K items 2.02,9.01
- 2024-05-08 officer change 8-K items 5.02,7.01,9.01
- 2024-04-29 filing ARS
- 2024-04-26 filing Proxy statement
- 2024-04-11 filing 8-K items 8.01,9.01
- 2024-04-10 filing RW
- 2024-03-28 filing Annual report (10-K)
- 2024-03-28 filing 8-K items 2.02,9.01
- 2024-03-18 filing 8-K items 5.03,9.01
- 2024-03-12 officer change 8-K items 5.02,7.01,9.01
- 2024-02-09 filing S-1/A
- 2024-01-18 filing S-1/A
- 2023-12-29 filing 8-K items 3.01
- 2023-12-20 filing Registration (S-1)
- 2023-12-11 officer change 8-K items 5.02,7.01,9.01
- 2023-11-14 filing Quarterly report (10-Q)
- 2023-11-14 filing 8-K items 2.02,9.01
- 2023-08-11 filing S-8
- 2023-08-10 filing Quarterly report (10-Q)
- 2023-08-10 filing 8-K items 2.02,9.01
- 2023-06-15 officer change 8-K items 5.02,5.07,9.01
- 2023-06-14 officer change 8-K items 5.02
- 2023-05-26 filing UPLOAD
- 2023-05-11 filing Quarterly report (10-Q)
- 2023-05-11 filing 8-K items 2.02,9.01
- 2023-05-05 filing CORRESP
- 2023-05-03 filing UPLOAD
- 2023-04-28 filing Proxy statement
- 2023-04-28 filing DEFA14A
- 2023-03-30 filing Annual report (10-K)
- 2023-03-30 filing 8-K items 2.02,9.01
- 2023-03-24 filing 8-K items 5.03,9.01
- 2023-02-10 officer change 8-K items 5.02,9.01
- 2023-01-03 officer change 8-K items 5.02
- 2022-11-15 filing 8-K items 7.01,9.01
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-14 filing 8-K items 2.02,9.01
- 2022-10-03 officer change 8-K items 5.02,9.01
- 2022-09-19 filing 8-K items 5.03,9.01
- 2022-09-19 name change Name changed from CELSION CORP
- 2022-09-19 name change Name changed from Celsion CORP
- 2022-08-15 filing S-8
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-08-15 filing 8-K items 2.02,9.01
- 2022-07-19 officer change 8-K items 5.02,7.01,9.01
- 2022-06-14 filing 8-K items 5.07
- 2022-05-25 filing 8-K items 1.01,8.01,9.01
- 2022-05-25 filing 424B5
- 2022-05-16 filing Quarterly report (10-Q)
- 2022-05-16 filing 8-K items 2.02,9.01
- 2022-04-29 filing Proxy statement
- 2022-04-08 filing 424B5
- 2022-04-07 filing 8-K items 1.01,8.01,9.01
- 2022-03-31 filing Annual report (10-K)
- 2022-03-31 filing 8-K items 2.02,9.01
- 2022-03-16 filing 8-K items 8.01
- 2022-03-04 filing 8-K items 3.03,8.01,9.01
- 2022-02-28 filing 8-K items 3.03,5.03,5.07,8.01,9.01
- 2022-01-26 filing DEFA14A
- 2022-01-25 filing Proxy statement
- 2022-01-14 filing PRE 14A
- 2022-01-14 filing 8-K items 3.03,5.03,8.01,9.01
- 2022-01-12 filing 424B5
- 2022-01-12 filing 424B5
- 2022-01-11 filing 8-K items 1.01,3.03,5.03,8.01,9.01
- 2021-12-30 officer change 8-K items 5.02
- 2021-12-10 filing 8-K items 5.03,9.01
- 2021-12-03 filing 8-K items 3.01
- 2021-11-15 filing Quarterly report (10-Q)
- 2021-11-15 filing 8-K items 2.02,9.01
- 2021-08-12 filing Quarterly report (10-Q)
- 2021-08-12 filing 8-K items 2.02,9.01
- 2021-06-21 filing 8-K items 1.01,2.03
- 2021-06-10 officer change 8-K items 5.02,5.07,9.01
- 2021-06-07 filing 8-K items 8.01,9.01
- 2021-06-07 filing DEFA14A
- 2021-06-04 filing 8-K items 8.01,9.01
- 2021-06-04 filing DEFA14A
- 2021-05-27 filing DEFA14A
- 2021-05-14 filing Quarterly report (10-Q)
- 2021-05-14 filing 8-K items 2.02,9.01
- 2021-04-20 filing Proxy statement
- 2021-04-12 filing PRER14A
- 2021-04-08 filing PRE 14A
- 2021-04-02 filing 8-K items 1.01,8.01,9.01
- 2021-04-02 filing 424B5
- 2021-03-30 filing EFFECT
- 2021-03-26 filing CORRESP
- 2021-03-24 filing UPLOAD
- 2021-03-19 filing S-3
- 2021-03-19 filing Annual report (10-K)
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-12 (within 30 days) 10-Q filed
- 2026-11-12 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-28 (within 30 days) S-1/A filed
- 2026-10-27 (within 30 days) S-1 filed
- 2026-10-27 (within 30 days) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-21 (within 30 days) 8-K filed: Item 1.01 material agreement; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-10-13 (older) DRS filed
- 2026-09-29 (older) 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:IMNN The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 749647 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | IMNN / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 521256615 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000749647 | SEC EDGAR / IRS |
| CUSIP | 15117N701 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000749647 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$14,495,028 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-19 22:39 UTC | Report an error |
| Total assets (at 2025-12-31) | $12,288,116 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-19 22:39 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $7,061,876 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-19 22:39 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $8,781,059 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-19 22:39 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
| Business address | 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:39 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$13,896,624 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-19 22:39 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $280,572 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-19 22:39 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,008,765 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-19 22:39 UTC | Report an error |
| Form D total offering amount (D filed 2025-05-28) | $3,250,001 | 2025-05-28 | D | as filed | 2026-11-19 22:39 UTC | Report an error |
| Form D total amount sold (D filed 2025-05-28) | $3,250,001 | 2025-05-28 | D | as filed | 2026-11-19 22:39 UTC | Report an error |
| Form D industry group | Biotechnology | 2025-05-28 | D | as filed | 2026-11-19 22:39 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-05-28 | D | as filed | 2026-11-19 22:39 UTC | Report an error |
| Form D date of first sale | 2025-05-27 | 2025-05-28 | D | as filed | 2026-11-19 22:39 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001493152-26-051203
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$3,750,287 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051203 | 2026-11-19 22:39 UTC | Report an error |
| Interest expense | $264,133 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051203 | 2026-11-19 22:39 UTC | Report an error |
| Cash and cash equivalents | $4,039,298 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051203 | 2026-11-19 22:39 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-12 Filing 10-Q filed
- 2026-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-28 Filing S-1/A filed
- 2026-10-27 Filing S-1 filed
- 2026-10-27 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-21 Filing 8-K filed: Item 1.01 material agreement; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-10-13 Filing DRS filed
- 2026-09-29 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-08-11 Filing 8-K filed: Item 5.02 officer or director change
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-06-30 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-06-17 Filing S-8 filed
- 2026-06-16 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-06-04 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-12 Filing 10-Q filed
- 2026-05-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-04 Filing ARS filed
- 2026-05-04 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-05-04 Filing DEF 14A filed
- 2026-03-31 Filing 10-K filed
- 2026-03-31 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-03-23 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-03-23 Filing 424B5 filed
- 2026-02-05 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | $257,685 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 2 | Riverview Capital Advisers, LLC | $247,765 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $83,601 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | $56,302 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 5 | VANGUARD FIDUCIARY TRUST CO | $23,619 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 6 | NORTHERN TRUST CORP | $18,409 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 7 | UBS Group AG | $9,261 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 8 | BlackRock, Inc. | $7,946 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 9 | Tower Research Capital LLC (TRC) | $7,035 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
| 10 | WELLS FARGO & COMPANY/MN | $5,948 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:39 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 2 sources. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
USAspending (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchIMUNON, INC. · exact legal name · sx:usaspending:T47TFH41YJF8 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/749647.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000749647. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.